Ryan Moreira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ryan Moreira has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Wilfred A. van der Donk
University of Illinois at Urbana-Champaign
11 shared publications - Yi Yang
Department of Chemistry and Howard Hughes Medical Institute, University of Illinois at Urbana-Champaign, 600 S Mathews Ave, Urbana, IL, United States, 61801
7 shared publications - Scott D. Taylor
University of Waterloo 200 University Ave. West
4 shared publications - Chandrashekhar Padhi
Department of Chemistry and Howard Hughes Medical Institute, University of Illinois at Urbana−Champaign, Urbana, Illinois 61801, United States
3 shared publications - Songyi Xue
Department of Chemistry and Howard Hughes Medical Institute, University of Illinois at Urbana-Champaign, 600 S Mathews Ave, Urbana, IL, United States, 61801
3 shared publications - Chunyu Wu
Process Research and Development, Merck & Co., Inc., Rahway, NJ, USA
2 shared publications
Latest Publications
- 31 August 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (36) , 11303-11308
Cyanamide-Induced Desulfhydration Enables Access to α,β-Dehydropeptides
Dehydroamino acids are found in natural products, disease-associated proteins, and are used for the diversification of proteins and peptides. The synthesis of peptide sequences containing dehydroamino acids remains nontrivial and only a few chemical methods allow for their incorporation. We report the conversion of amino acid residues bearing β-thiols into dehydroamino acids through the treatment of unprotected peptides and proteins with cyanamide under mild, fully aqueous conditions that are compatible with commonly used buffer salts.
- 31 August 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (36) , 11303-11308
Cyanamide-Induced Desulfhydration Enables Access to α,β-Dehydropeptides
Dehydroamino acids are found in natural products, disease-associated proteins, and are used for the diversification of proteins and peptides. The synthesis of peptide sequences containing dehydroamino acids remains nontrivial and only a few chemical methods allow for their incorporation. We report the conversion of amino acid residues bearing β-thiols into dehydroamino acids through the treatment of unprotected peptides and proteins with cyanamide under mild, fully aqueous conditions that are compatible with commonly used buffer salts.
- Open Access
- 27 July 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Cyanamide-induced desulfhydration enables access to α,β-dehydropeptides
Dehydroamino acids are found in natural products, disease-associated proteins, and are used for the diversification of proteins and peptides. The synthesis of peptide sequences containing dehydroamino acids remains non-trivial and only a few chemical methods allow for their incorporation. We report the conversion of amino acid residues bearing β-thiols into dehydroamino acids through the treatment of unprotected peptides and proteins with cyanamide under mild, fully aqueous conditions that are compatible with commonly used buffer salts.
- 27 July 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessCyanamide-induced desulfhydration enables access to α,β-dehydropeptides
Dehydroamino acids are found in natural products, disease-associated proteins, and are used for the diversification of proteins and peptides. The synthesis of peptide sequences containing dehydroamino acids remains non-trivial and only a few chemical methods allow for their incorporation. We report the conversion of amino acid residues bearing β-thiols into dehydroamino acids through the treatment of unprotected peptides and proteins with cyanamide under mild, fully aqueous conditions that are compatible with commonly used buffer salts.
- Open Access
- 10 June 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Cyanamide-induced desulfhydration enables access to α,β-dehydropeptides
Dehydroamino acids are found in natural products, disease-associated proteins, and are used for the diversification of proteins and peptides. The synthesis of peptide sequences containing dehydroamino acids remains non-trivial and only a few chemical methods allow for their incorporation. We report the conversion of amino acid residues bearing β-thiols into dehydroamino acids through the treatment of unprotected peptides and proteins with cyanamide under mild, fully aqueous conditions that are compatible with commonly used buffer salts.
- 10 June 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessCyanamide-induced desulfhydration enables access to α,β-dehydropeptides
Dehydroamino acids are found in natural products, disease-associated proteins, and are used for the diversification of proteins and peptides. The synthesis of peptide sequences containing dehydroamino acids remains non-trivial and only a few chemical methods allow for their incorporation. We report the conversion of amino acid residues bearing β-thiols into dehydroamino acids through the treatment of unprotected peptides and proteins with cyanamide under mild, fully aqueous conditions that are compatible with commonly used buffer salts.
- Open Access
Structure and Mechanism of a Two-component Lanthipeptide Toxin
The enterococcal cytolysin is a two-component lanthipeptide natural product that co-operatively kills mammalian cells and bacteria. It is a virulence factor in typically commensal strains of gut-dwelling Enterococcus faecalis and causes a fatal form of alcoholic hepatitis. Despite its clinical significance, little is known about the mechanism of action. We present here the molecular details of cytolysin’s remarkable bioactivity. A high-resolution cryo-electron microscopy structure revealed highly ordered tubular assemblies comprising the two subunits. We further demonstrate these structures disrupt the membranes of eukaryotic and bacterial cells. These results provide the first high-resolution structure of two distinct lanthipeptides interacting with one another and offer an explanation for the unique bioactivity of the cytolysin toxin.
Open AccessStructure and Mechanism of a Two-component Lanthipeptide Toxin
The enterococcal cytolysin is a two-component lanthipeptide natural product that co-operatively kills mammalian cells and bacteria. It is a virulence factor in typically commensal strains of gut-dwelling Enterococcus faecalis and causes a fatal form of alcoholic hepatitis. Despite its clinical significance, little is known about the mechanism of action. We present here the molecular details of cytolysin’s remarkable bioactivity. A high-resolution cryo-electron microscopy structure revealed highly ordered tubular assemblies comprising the two subunits. We further demonstrate these structures disrupt the membranes of eukaryotic and bacterial cells. These results provide the first high-resolution structure of two distinct lanthipeptides interacting with one another and offer an explanation for the unique bioactivity of the cytolysin toxin.
- Open Access
- 28 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-17
Combatting virulent gut bacteria by inhibiting the biosynthesis of a two-component lanthipeptide toxin
The enterococcal cytolysin is a toxic, two-component ribosomally synthesized and post-translationally modified peptide (RiPP) produced by pathogenic Enterococcus faecalis. Cytolysin-producing (C+) E. faecalis resides in the gut microbiome in a commensal role, but results in negative clinical outcomes in alcoholic hepatitis patients. To potentially combat cytolysin virulence, we report inhibitors of its maturation. An extracellular serine protease CylA that is essential for toxin activation is chosen as target. A series of α-aminopeptide boronic acids are designed and synthesized that block cytolysin maturation at low micromolar to nanomolar concentrations in vitro. A crystal structure of CylA provides insights into substrate recognition, autocatalytic activation of the enzyme, and toxin maturation. The inhibitors block hemolytic activity, reduce the amount of cytolysin, and attenuate expression of the cytolysin biosynthetic gene cluster without impeding cell growth. These studies provide a potential route to the development of treatments for cytolysin-induced disease states.
- 28 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-17
Open AccessCombatting virulent gut bacteria by inhibiting the biosynthesis of a two-component lanthipeptide toxin
The enterococcal cytolysin is a toxic, two-component ribosomally synthesized and post-translationally modified peptide (RiPP) produced by pathogenic Enterococcus faecalis. Cytolysin-producing (C+) E. faecalis resides in the gut microbiome in a commensal role, but results in negative clinical outcomes in alcoholic hepatitis patients. To potentially combat cytolysin virulence, we report inhibitors of its maturation. An extracellular serine protease CylA that is essential for toxin activation is chosen as target. A series of α-aminopeptide boronic acids are designed and synthesized that block cytolysin maturation at low micromolar to nanomolar concentrations in vitro. A crystal structure of CylA provides insights into substrate recognition, autocatalytic activation of the enzyme, and toxin maturation. The inhibitors block hemolytic activity, reduce the amount of cytolysin, and attenuate expression of the cytolysin biosynthetic gene cluster without impeding cell growth. These studies provide a potential route to the development of treatments for cytolysin-induced disease states.
- Open Access
- 26 June 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (27) , 23781-23796
Biosynthesis of Biphenomycin-like Macrocyclic Peptides by Formation and Cross-Linking of Ortho-Tyrosines
Ribosomally synthesized and posttranslationally modified peptides (RiPPs) are a growing class of natural products. Multinuclear nonheme iron-dependent oxidative enzymes (MNIOs, previously DUF692) are involved in a range of unprecedented biochemical reactions. Over 13,500 putative MNIO-encoding biosynthetic gene clusters (BGCs) have been identified by sequence similarity networks. In this study, we investigated a set of precursor peptides containing a conserved FHAFRF motif in MNIO-encoding BGCs. These BGCs contain genes encoding an MNIO, a RiPP recognition element-containing protein, an arginase, a hydroxylase, and a vitamin B12-dependent radical SAM enzyme (B12-rSAM). Using heterologous reconstitution of a representative BGC from Peribacillus simplex (pbs cluster) in E. coli, we demonstrated that the MNIO in conjunction with the partner protein catalyzes ortho-hydroxylation of each of the phenylalanine residues in the conserved FRF motif, the arginase forms an ornithine from the arginine, the ornithine residue is hydroxylated, and the B12-rSAM cross-links the ortho-Tyr side chains by a C-C linkage forming a macrocycle. A protease matures the RiPP to its final form. The elucidated structure shares close similarity to biphenomycins, a class of peptide antibiotics for which the biosynthetic pathway has not been characterized. Substrate scope studies suggest some tolerance of the MNIO and the B12-rSAM enzymes. This study expands the diverse array of posttranslational modifications catalyzed by MNIOs and B12-rSAM enzymes, deorphanizes biphenomycin biosynthesis, and provides a platform for the production of analogs from orthologous BGCs.
- 26 June 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (27) , 23781-23796
Open AccessBiosynthesis of Biphenomycin-like Macrocyclic Peptides by Formation and Cross-Linking of Ortho-Tyrosines
Ribosomally synthesized and posttranslationally modified peptides (RiPPs) are a growing class of natural products. Multinuclear nonheme iron-dependent oxidative enzymes (MNIOs, previously DUF692) are involved in a range of unprecedented biochemical reactions. Over 13,500 putative MNIO-encoding biosynthetic gene clusters (BGCs) have been identified by sequence similarity networks. In this study, we investigated a set of precursor peptides containing a conserved FHAFRF motif in MNIO-encoding BGCs. These BGCs contain genes encoding an MNIO, a RiPP recognition element-containing protein, an arginase, a hydroxylase, and a vitamin B12-dependent radical SAM enzyme (B12-rSAM). Using heterologous reconstitution of a representative BGC from Peribacillus simplex (pbs cluster) in E. coli, we demonstrated that the MNIO in conjunction with the partner protein catalyzes ortho-hydroxylation of each of the phenylalanine residues in the conserved FRF motif, the arginase forms an ornithine from the arginine, the ornithine residue is hydroxylated, and the B12-rSAM cross-links the ortho-Tyr side chains by a C-C linkage forming a macrocycle. A protease matures the RiPP to its final form. The elucidated structure shares close similarity to biphenomycins, a class of peptide antibiotics for which the biosynthetic pathway has not been characterized. Substrate scope studies suggest some tolerance of the MNIO and the B12-rSAM enzymes. This study expands the diverse array of posttranslational modifications catalyzed by MNIOs and B12-rSAM enzymes, deorphanizes biphenomycin biosynthesis, and provides a platform for the production of analogs from orthologous BGCs.
- Open Access
Biosynthesis of Macrocyclic Peptides by Formation and Crosslinking of ortho -Tyrosines
Ribosomally synthesized and posttranslationally modified peptides (RiPPs) are a growing class of natural products that possess many activities that are of potential translational interest. Multinuclear non-heme iron dependent oxidative enzymes (MNIOs), until recently termed domain of unknown function 692 (DUF692), have been gaining interest because of their involvement in a range of biochemical reactions that are remarkable from a chemical perspective. Over 13,500 putative MNIO-encoding biosynthetic gene clusters (BGCs) have been identified by sequence similarity networks (SSNs). In this study, we identified a set of precursor peptides containing a conserved FHAFRF-motif in MNIO-encoding BGCs. These BGCs follow a conserved synteny with genes encoding an MNIO, a RiPP recognition element (RRE)-containing partner protein, an arginase, and a B12-dependent radical SAM enzyme (rSAM). Using heterologous reconstitution of a representative BGC from Peribacillus simplex ( pbs cluster) in E. coli , we demonstrated that the MNIO in conjunction with the partner protein catalyzes ortho -hydroxylation of each of the phenylalanine residues in the conserved FRF-motif, the arginase forms an ornithine by deguanidination of the arginine in the motif, and the B12-rSAM crosslinks the ortho -Tyr side side chains by a C-C linkage forming a novel macrocyclic molecule. Substrate scope studies suggested tolerance of the MNIO and the B12-rSAM towards substituting the Phe residues with tyrosines in the conserved motif with the position of hydroxylation and crosslinking being maintained. Overall, this study expands the diverse array of posttranslational modifications catalyzed by MNIOs and B12-rSAM enzymes. TOC Graphic:
Open AccessBiosynthesis of Macrocyclic Peptides by Formation and Crosslinking of ortho -Tyrosines
Ribosomally synthesized and posttranslationally modified peptides (RiPPs) are a growing class of natural products that possess many activities that are of potential translational interest. Multinuclear non-heme iron dependent oxidative enzymes (MNIOs), until recently termed domain of unknown function 692 (DUF692), have been gaining interest because of their involvement in a range of biochemical reactions that are remarkable from a chemical perspective. Over 13,500 putative MNIO-encoding biosynthetic gene clusters (BGCs) have been identified by sequence similarity networks (SSNs). In this study, we identified a set of precursor peptides containing a conserved FHAFRF-motif in MNIO-encoding BGCs. These BGCs follow a conserved synteny with genes encoding an MNIO, a RiPP recognition element (RRE)-containing partner protein, an arginase, and a B12-dependent radical SAM enzyme (rSAM). Using heterologous reconstitution of a representative BGC from Peribacillus simplex ( pbs cluster) in E. coli , we demonstrated that the MNIO in conjunction with the partner protein catalyzes ortho -hydroxylation of each of the phenylalanine residues in the conserved FRF-motif, the arginase forms an ornithine by deguanidination of the arginine in the motif, and the B12-rSAM crosslinks the ortho -Tyr side side chains by a C-C linkage forming a novel macrocyclic molecule. Substrate scope studies suggested tolerance of the MNIO and the B12-rSAM towards substituting the Phe residues with tyrosines in the conserved motif with the position of hydroxylation and crosslinking being maintained. Overall, this study expands the diverse array of posttranslational modifications catalyzed by MNIOs and B12-rSAM enzymes. TOC Graphic:
- 24 December 2024
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 11 (1) , 226-237
The Calcium-Dependent Antibiotics: Structure–Activity Relationships and Determination of Their Lipid Target
The calcium-dependent antibiotics (CDAs) are a group of seven closely related membrane-active cyclic lipopeptide antibiotics (cLPAs) first isolated in the early 1980s from the fermentation broth of Streptomyces coelicolor. Their target was unknown, and the mechanism of action is uncertain. Herein, we report new routes for the synthesis of CDA4b and its analogues, explore the structure-activity relationships at its lipid tail and at positions 3, 9, and 11, and determine the CDAs' lipid target. A CDA4b analogue in which the epoxide group in CDA's 6-carbon lipid was replaced with a cyclopropyl group was 4-fold more active than CDA4b which suggests that the epoxide group is not acting as an electrophile to form a covalent bond with CDA4b's target. The activity of this cyclopropyl analogue was significantly increased by extending the length of the lipid to 10 carbons. Studies with analogues in which d-HOAsn9 is replaced with d-Asn9 or d-Ser9 reveal that the hydroxy group of the d-HOAsn9 residue is not crucial for CDAs' activity, while the amide moiety is important for activity. The l-Trp residue at position 11 could be replaced with l-kynurenine (l-Kyn) without significant loss of activity, while replacing the d-Trp residue at position 3 with d-Kyn resulted in a significant loss of activity. MIC values determined in the presence and absence of exogenous phospholipids and fluorescence spectroscopy studies using natural CDAs and CDA4b analogues containing Kyn and model membranes revealed that the CDAs' primary lipid target is cardiolipin, a target that is unique among the broader class of known calcium-dependent antibiotics.
- 24 December 2024
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 11 (1) , 226-237
The Calcium-Dependent Antibiotics: Structure–Activity Relationships and Determination of Their Lipid Target
The calcium-dependent antibiotics (CDAs) are a group of seven closely related membrane-active cyclic lipopeptide antibiotics (cLPAs) first isolated in the early 1980s from the fermentation broth of Streptomyces coelicolor. Their target was unknown, and the mechanism of action is uncertain. Herein, we report new routes for the synthesis of CDA4b and its analogues, explore the structure-activity relationships at its lipid tail and at positions 3, 9, and 11, and determine the CDAs' lipid target. A CDA4b analogue in which the epoxide group in CDA's 6-carbon lipid was replaced with a cyclopropyl group was 4-fold more active than CDA4b which suggests that the epoxide group is not acting as an electrophile to form a covalent bond with CDA4b's target. The activity of this cyclopropyl analogue was significantly increased by extending the length of the lipid to 10 carbons. Studies with analogues in which d-HOAsn9 is replaced with d-Asn9 or d-Ser9 reveal that the hydroxy group of the d-HOAsn9 residue is not crucial for CDAs' activity, while the amide moiety is important for activity. The l-Trp residue at position 11 could be replaced with l-kynurenine (l-Kyn) without significant loss of activity, while replacing the d-Trp residue at position 3 with d-Kyn resulted in a significant loss of activity. MIC values determined in the presence and absence of exogenous phospholipids and fluorescence spectroscopy studies using natural CDAs and CDA4b analogues containing Kyn and model membranes revealed that the CDAs' primary lipid target is cardiolipin, a target that is unique among the broader class of known calcium-dependent antibiotics.
- Open Access
- 4 September 2024
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 5 (10) , 1060-1073
Bibacillin 1: a two-component lantibiotic from Bacillus thuringiensis
Here we describe the structure, bioactivity, and action mechanism of bibacillin 1 – a two-component lantibiotic from Bacillus thuringiensis.
- 4 September 2024
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 5 (10) , 1060-1073
Open AccessBibacillin 1: a two-component lantibiotic from Bacillus thuringiensis
Here we describe the structure, bioactivity, and action mechanism of bibacillin 1 – a two-component lantibiotic from Bacillus thuringiensis.
- Open Access
Bibacillin 1: A two-component lantibiotic from Bacillus thuringiensis
Here we describe bibacillin 1 – a two-component lantibiotic from Bacillus thuringiensis . The peptides that comprise bibacillin 1 are modified by a class II lanthipeptide synthetase Bib1M producing two peptides with non-overlapping ring patterns that are reminiscent of cerecidin and the short component of the enterococcal cytolysin (CylLS”), a virulence factor associated with human disease. Stereochemical analysis demonstrated that each component contains LL-methyllanthionine and DL-lanthionine. The mature bibacillin 1 peptides showed cooperative bactericidal activity against Gram-positive bacteria, including members of ESKAPE pathogens, and weak hemolytic activity. Optimal ratio studies suggest that bibacillin 1 works best when the components are present in a 1:1 ratio, but near optimal activity was observed at ratios strongly favouring one component over the other, suggesting that the two peptides may have different but complementary targets. Mechanism of action studies suggest a lipid II-independent killing action distinguishing bibacillin 1 from two other two-component lantibiotics haloduracin and lacticin 3147. One of the two components of bibacillin 1 showed cross reactivity with the cytolysin regulatory system. These result support the involvement of bibacillin 1 in quorum sensing and raise questions about the impact of CylL S ”-like natural products on lanthipeptide expression in diverse bacterial communities.
Open AccessBibacillin 1: A two-component lantibiotic from Bacillus thuringiensis
Here we describe bibacillin 1 – a two-component lantibiotic from Bacillus thuringiensis . The peptides that comprise bibacillin 1 are modified by a class II lanthipeptide synthetase Bib1M producing two peptides with non-overlapping ring patterns that are reminiscent of cerecidin and the short component of the enterococcal cytolysin (CylLS”), a virulence factor associated with human disease. Stereochemical analysis demonstrated that each component contains LL-methyllanthionine and DL-lanthionine. The mature bibacillin 1 peptides showed cooperative bactericidal activity against Gram-positive bacteria, including members of ESKAPE pathogens, and weak hemolytic activity. Optimal ratio studies suggest that bibacillin 1 works best when the components are present in a 1:1 ratio, but near optimal activity was observed at ratios strongly favouring one component over the other, suggesting that the two peptides may have different but complementary targets. Mechanism of action studies suggest a lipid II-independent killing action distinguishing bibacillin 1 from two other two-component lantibiotics haloduracin and lacticin 3147. One of the two components of bibacillin 1 showed cross reactivity with the cytolysin regulatory system. These result support the involvement of bibacillin 1 in quorum sensing and raise questions about the impact of CylL S ”-like natural products on lanthipeptide expression in diverse bacterial communities.